➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 25, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Permethrin

A generic version of PERMETHRIN was approved as permethrin by ACTAVIS LABS on January 23rd, 1998.

  Start Trial

Drug patent expirations by year for PERMETHRIN
Drug Prices for PERMETHRIN

See drug prices for PERMETHRIN

Drug Sales Revenue Trends for PERMETHRIN

See drug sales revenues for PERMETHRIN

Recent Clinical Trials for PERMETHRIN

Identify potential brand extensions & 505(b)(2) entrants

Manhiça Health Research Centre (CISM)Phase 2
Chittagong Medical CollegePhase 2
The Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD)Phase 2

See all PERMETHRIN clinical trials

Pharmacology for PERMETHRIN
Drug ClassPyrethroid
Medical Subject Heading (MeSH) Categories for PERMETHRIN

US Patents and Regulatory Information for PERMETHRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs PERMETHRIN permethrin CREAM;TOPICAL 074806-001 Jan 23, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic PERMETHRIN permethrin LOTION;TOPICAL 075014-001 Mar 28, 2000 OTC No No   Start Trial   Start Trial   Start Trial
Encube Ethicals PERMETHRIN permethrin CREAM;TOPICAL 211303-001 Apr 3, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo Israel PERMETHRIN permethrin CREAM;TOPICAL 076369-001 Apr 21, 2003 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.